Loading…
Serum testosterone bioassay evaluation in a large male cohort
Summary Objective To assess if a cell‐based readout of androgen action in serum demonstrates a closer association with recognized classical parameters of androgen action in men than current measures of serum testosterone (T). Design To develop, validate and utilize a mammalian cell‐based assay to...
Saved in:
Published in: | Clinical endocrinology (Oxford) 2010-01, Vol.72 (1), p.87-98 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Summary
Objective To assess if a cell‐based readout of androgen action in serum demonstrates a closer association with recognized classical parameters of androgen action in men than current measures of serum testosterone (T).
Design To develop, validate and utilize a mammalian cell‐based assay to measure specifically bioactive T and determine if this measure is a physiologically relevant fraction of serum T.
Measurements and participants We have developed a specific serum T bioassay using human prostate cancer cells. A rapid 5‐min exposure to 100% serum followed by serum withdrawal confers specificity of the assay to serum T and provides sufficient sensitivity to measure T in male serum samples. Matrix effects were experimentally discounted as a confounding issue. A total of 960 male serum samples from the Florey Adelaide Male Ageing Study (FAMAS) with previous comprehensive cohort data and serum measurements were utilized.
Results Bioassay T measurement in the 960 FAMAS serum samples returned a median of 10·7 nmol/l (1·7–45·4), and was most closely related to immunoassayed total T, but not immunoassayed bioavailable T or calculated free T. Immunoassayed total T demonstrated a positive association with isometric grip‐strength (R2 = 0·127, P |
---|---|
ISSN: | 0300-0664 1365-2265 |
DOI: | 10.1111/j.1365-2265.2009.03595.x |